Canadian Pediatric Surveillance Program

Canadian Pediatric Surveillance Program
Name	Canadian Pediatric Surveillance Program
Formation	1996
Founder	Canadian Paediatric Society
Type	Research network
Purpose	Sentinel surveillance for rare pediatric conditions
Headquarters	Ottawa
Region served	Canada
Leader title	Director
Parent organization	Canadian Paediatric Society

Canadian Pediatric Surveillance Program The Canadian Pediatric Surveillance Program conducts sentinel surveillance of rare and serious pediatric conditions across Canada. It links pediatricians and pediatric subspecialists with public health agencies such as Public Health Agency of Canada and academic institutions like the University of Toronto to inform policy on conditions including pediatric inflammatory multisystem syndrome and congenital cytomegalovirus. The program integrates clinical networks, epidemiologic methods, and laboratory collaborations involving partners such as Provincial health ministries and national surveillance initiatives.

Overview

The program operates a clinician-reporting network of pediatricians and subspecialists drawn from organizations including the Canadian Paediatric Society, the Royal College of Physicians and Surgeons of Canada, and provincial associations in Ontario, Quebec, British Columbia, Alberta, and other provinces. It conducts active surveillance using monthly reporting forms and specialized questionnaires to capture incident cases of targeted conditions such as pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, neonatal herpes simplex, and Kawasaki disease. Data are used to estimate incidence, describe clinical presentations, and support guideline development by bodies like the National Advisory Committee on Immunization.

History and Development

Established in 1996 by the Canadian Paediatric Society in collaboration with the Public Health Agency of Canada and provincial partners, the program evolved from smaller pediatric case registries and surveillance pilots linked to institutions such as the Hospital for Sick Children (Toronto) and the Children’s Hospital of Eastern Ontario. Early work drew on precedent from international systems like the British Paediatric Surveillance Unit and the Australian Paediatric Surveillance Unit, adapting methods to the Canadian federated health context involving Health Canada and provincial health authorities. Over time, the program expanded its case definitions, introduced web-based reporting platforms with involvement from university research groups at the University of British Columbia and McGill University, and collaborated on outbreak and vaccine safety investigations with agencies such as the Centers for Disease Control and Prevention.

Governance and Funding

Governance is overseen by a steering committee comprising representatives of the Canadian Paediatric Society, academic pediatric researchers from institutions including the University of Calgary and Dalhousie University, and liaisons from federal and provincial health departments. Funding streams have included contributions from the Public Health Agency of Canada, research grants from the Canadian Institutes of Health Research, and project-specific support from foundations and industry partners in vaccine research such as collaborations with manufacturers involved in immunization programs. Ethical oversight and data custodianship involve university research ethics boards at sites like the University of Montreal and data-sharing agreements with provincial health data custodians.

Surveillance Methods and Case Ascertainment

The program uses active surveillance through monthly reporting by clinicians identified via the Canadian Paediatric Society membership lists, the Royal College of Physicians and Surgeons of Canada specialty registries, and specialty societies in fields such as pediatric neurology, pediatric infectious diseases, and neonatology. Case definitions are developed with clinical experts from tertiary centers including Montreal Children’s Hospital and BC Children’s Hospital and aligned with international case definitions from organizations like the World Health Organization. Data collection combines standardized forms, follow-up questionnaires, and specimen linkage to provincial laboratories such as Public Health Ontario Laboratory for confirmatory testing; analytic methods employ epidemiologic techniques taught in programs at the University of Ottawa and the London School of Hygiene & Tropical Medicine.

Key Studies and Findings

The program has produced surveillance-derived estimates for conditions like congenital cytomegalovirus, neonatal herpes simplex virus, hemolytic uremic syndrome, and pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 pandemic. It informed national burden estimates cited by advisory committees such as the National Advisory Committee on Immunization and contributed to multi-center studies with academic partners including McMaster University and Queen’s University. Findings have clarified age distributions, risk factors, clinical outcomes, and healthcare utilization patterns, and have contributed data used in systematic reviews published in journals associated with institutions like the Canadian Medical Association.

Impact on Policy and Public Health Practice

Surveillance outputs have informed provincial immunization policy decisions in Nova Scotia, Manitoba, and Saskatchewan, clinical practice guidelines from the Canadian Paediatric Society, and outbreak responses coordinated with the Public Health Agency of Canada and provincial public health laboratories. Data from the program supported vaccine policy deliberations by the National Advisory Committee on Immunization and fed into recommendations on screening and management from specialty societies such as the Canadian Paediatric Surveillance Unit collaborators and guideline panels from tertiary centers like the Hospital for Sick Children (Toronto).

Criticisms and Limitations

Limitations cited by academics at institutions such as the University of British Columbia and McGill University include potential under-ascertainment due to voluntary clinician reporting, reporting fatigue among members of the Canadian Paediatric Society, variable case ascertainment across provinces like Newfoundland and Labrador and Yukon, and delays in laboratory confirmation from provincial labs. Methodologic critiques echo concerns raised in comparative evaluations of the British Paediatric Surveillance Unit and emphasize the need for enhanced data linkage with administrative datasets held by provincial data stewards and collaborations with research funding agencies including the Canadian Institutes of Health Research for sustainability.

Category:Health organizations based in Canada Category:Pediatrics in Canada